Registration is now open!

Our annual conference is free, but registration is required to attend and in order to receive our conference program with links to all sessions. We're also pleased to announce UVM Center on Rural Addiction's Lunch and Learn on Friday, October 8th from 12-1:15 PM on 
Rural Vaping and Tobacco Use: Prevalence, Considerations, and Interventions.

 

Register Button

Conference Agenda and Speakers 

We are delighted to preview our conference agenda (PDF) for this year's 9th annual conference.

Thursday, October 7, 2021

8:30 - 8:40 AM

Opening Remarks: Stephen T. Higgins, PhD, Director, Vermont Center on  Behavior and Health, Professor, Departments of Psychiatry and Psychological Science, University of Vermont

8:40 - 8:50 AM

Welcome: Patricia A Prelock, PhD, Senior Vice President and Provost, University of Vermont

8:50 - 8:55 AM Video Welcome: United States Senator Patrick J. Leahy of Vermont
9:00 - 11:25 AM

Paper Session 1

Session Chair: Jennifer Tidey, PhD, Professor of Behavioral and Social Science, Associate Dean for Research, Brown University School of Public Health

 9:00 - 9:25 AM

Digital Interventions
Amanda Graham, PhD, Chief of Innovations, Truth Initiative; Adjunct Professor of Medicine, Mayo Clinic College of Medicine and Science

 9:30 - 9:55 AMQuitlines
Christine Sheffer, PhD, Director of Research and Evaluation Roswell Park Cessation Services, Professor of Oncology, Department of Health Behavior, Roswell Park Comprehensive Cancer Center
 10:00 - 10:25 AME-cigarettes for Smoking Cessation: The Latest Cochrane Evidence
Jamie Hartmann-Boyce, PhD, Senior Research Fellow, Nuffield Department of Primary Care Health Sciences, University of Oxford; Editor, Cochrane Tobacco Addiction Group
 10:30 - 10:55 AMImpacts of State-Level Tobacco Flavor Bans
Michael Siegel, MD, Visiting Professor, Department of Public Health and Community Medicine, Tufts University School of Medicine
 11:00 - 11:25 AMAudience Q&A
11:30 - 12:30 PMKeynote Address

 

Innovations to Reduce Cigarette Smoking

Neal L Benowitz, MD, Emeritus Professor of Medicine and Bioengineering & Therapeutic Sciences and Chief of the Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco (UCSF)

12:30 - 1:30 PMLunch
1:30 - 3:55 PM

Paper Session 2

Session Chair: Elias Klemperer, PhD, Assistant Professor of Psychiatry and Psychological Science, Vermont Center on Behavior and Health, Larner College of Medicine, University of Vermont

 1:30 - 1:55 PMSmoking Cessation Among Those with Mental Illness
Judith (Jodi) Prochaska, PhD, Professor, Department of Medicine, Stanford University, Stanford, CA
 2:00 - 2:25 PMSmoking-Cessation Reach and Effectiveness
Danielle E. McCarthy, PhD, Professor, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
 2:30 - 2:55 PMMedication Sampling and Smoking Cessation
Matthew Carpenter, PhD, Professor, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina
 3:00 - 3:25 PMSmoking Cessation with Pregnant Women: Financial Incentives
Stephen T. Higgins, PhD, Director, Vermont Center on Behavior and Health, Professor, Departments of Psychiatry and Psychological Science, University of Vermont
 3:30 - 3:55 PMAudience Q&A
4:00 - 4:15 PMBreak
4:15 - 5:00 PM

Poster Session 1

Group 1: Youth and Young Adults

Group 2: Smoking and Cardiac Rehabilitation

Group 3: Changes in CPD

5:00 - 5:15 PMBreak
5:15 - 6:00 PM

Poster Session 2

Group 1: ENDS

Group 2: Incentives and Opioid Use

Group 3: Behavioral Economics


Friday, October 8, 2021

8:00 - 10:25 AM

Paper Session 3

Session Chair: Andrea Villanti, PhD, MPH, Associate Professor, Departments of Psychiatry and Psychological Science, Vermont Center on Behavior and Health, Larner College of Medicine, University of Vermont

 8:00 - 8:25 AMPotential Anticipated and Unanticipated Impacts of FDA Bans on Characterizing Flavors in Cigarettes and Cigars
Kevin Schroth, JD, Associate Professor, Department of Health Behavior, Society and Policy, Rutgers University School of Public Health
 8:30 - 8:55 AMReducing Smoking in Disadvantaged and Racial/Ethnic Minority Populations
Pebbles Fagan, PhD, MPH, FACP, Professor and Director of the Center for the Study of Tobacco, Department of Health Behavior and Health Education, University of Arkansas for Medical Sciences Fay W. Boozman College of Public Health
 9:00 - 9:25 AMPotential Effects of a Menthol Ban on Smoking Behavior in Menthol Cigarette Smokers
Michael Kotlyar, PharmD, Associate Professor, Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy
 9:30 - 9:55 AMPotential Impact of a Menthol Ban on Smoking Prevalence
K. Michael Cummings, PhD, MPH, Professor, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina
 10:00 - 10:25 AMAudience Q&A
10:30 - 10:45 AMBreak 
10:45 - 12:00 PM

Paper Session 4

Session Chair: Dustin Lee, PhD, Assistant Professor of Psychiatry and Behavioral Sciences, Johns Hopkins Medicine, Johns Hopkins University

 10:50 - 11:15 AMPotential Impacts of Menthol Ban on Cigarette Smoking in Disadvantaged and Racial/Ethnic Minority Populations
Shyanika W. Rose, PhD, MA Assistant Professor, University of Kentucky College of Medicine, Behavioral Science and Center for Health Equity Transformation
 11:20 - 11:45 AMHypothetical Impacts of Flavored Cigar Sales Restrictions on Cigar Use Behavior
Julia Chen-Sankey, PhD, MPP, Assistant Professor, Center for Tobacco Studies, Rutgers Biomedical and Health Sciences, Department of Health Behavior, Society and Policy, Rutgers School of Public Health
 11:50 - 12:00 PMAudience Q&A
12:00 - 1:15 PM


Lunch and Learn
presented by the UVM Center on Rural Addiction (CORA)

Rural Vaping and Tobacco Use: Prevalence, Considerations, and Interventions

Lunch Session Chair: Stacey Sigmon, PhD, CORA Director and Professor, Departments of Psychiatry and Psychological Science, Vermont Center on Behavior and Health, Larner College of Medicine, University of Vermont

  • Growing Disparities Between Rural and Urban Smoking in the US 
    Stephen T. Higgins, PhD, Director, Vermont Center on Behavior and Health, Professor, Departments of Psychiatry and Psychological Science, Larner College of Medicine, University of Vermont
  • The Prevalence of Smoking and Vaping Among Rural Youth And Promising Approaches For Addressing It
    Andrea Villanti, PhD, MPH, Associate Professor, Departments of Psychiatry and Psychological Science, Vermont Center on Behavior and Health, Larner College of Medicine, University of Vermont
  • Feasibility of a Remotely-Delivered Contingency Management Intervention for Vaping Abstinence among Young Adults
    Bethany Raiff, PhD, BCBA-D, Director, Health and Behavioral Integrated Treatments (HABIT) Research Unit, Professor, Department of Psychology, College of Science and Mathematics, Assistant Professor, Family Medicine, School of Osteopathic Medicine (SOM), Rowan University
1:15 - 3:15 PMPaper Session 5

Session Chair: Eric Thrailkill, PhD, Assistant Professor, Departments of Psychiatry and Psychological Science, Vermont Center on Behavior and Health, Larner College of Medicine, University of Vermont
 1:20 - 1:45 PMNicotine Reduction and Smoking
Eric C. Donny, PhD, Director, Tobacco Control Center of Excellence, Professor, Departments of Physiology & Pharmacology, Wake Forest University
 1:50 - 2:15 PMNicotine Reduction and Smoking in Vulnerable Populations
Jennifer Tidey, PhD, Professor of Behavioral and Social Science, Associate Dean for Research, Brown University School of Public Health
 2:20 - 2:45 PMMessaging Around Nicotine Content in Cigarettes
Andrea C. Villanti, PhD, MPH, Associate Professor, Departments of Psychiatry and Psychological Science, Vermont Center on Behavior and Health, Larner College of Medicine, University of Vermont
 2:50 - 3:15 PMAudience Q&A
 3:15 ADJOURN


Keynote Speaker Announced

Neal Benowitz MDVCBH is delighted to announce our 9th Annual VCBH Conference Keynote Speaker Neal L. Benowitz, MD, Emeritus Professor of Medicine and Bioengineering & Therapeutic Sciences and Chief of the Division of Clinical Pharmacology and Experimental Therapeutics at the University of California, San Francisco (UCSF).

Dr. Benowitz’s research interests have focused primarily on the human pharmacology and toxicology of nicotine and cannabis. He has published more than 700 research papers and contributed to several US Surgeon Generals' reports on smoking and health in the areas of nicotine addiction and the cardiovascular effects of tobacco use, including cigarettes, water pipe and electronic cigarette use. Dr Benowitz maintains an active clinical practice in cardiovascular medicine and medical toxicology and is a member of a number of medical societies, including the American Society for Clinical Investigation and the Association of American Physicians. He has served as a member of the National Institutes of Health Pharmacology Study Section, the FDA Nonprescription Drug Advisory Committee and the FDA Tobacco Products Science Advisory Committee as well as president of the American Society for Clinical Pharmacology and Therapeutics and president of the Society for Research on Nicotine and Tobacco.

Dr. Benowitz received his medical degree from the University of Rochester School of Medicine in 1969, and then served as a resident in internal medicine at the Bronx Municipal Hospital Center from 1969 to 1971. He completed a postdoctoral fellowship in clinical pharmacology at UCSF and joined the faculty in 1974.

To keep up to date with the latest information, please join our mailing list 

or follow us on our social media channels

Twitter icon circle Facebook icon circle LinkedIn icon   YouTube Icon  

Please contact us with any questions.